Detalles de la búsqueda
1.
Health Care Cost Analysis of PPI or P-CAB-First Treatment in Patients With Gastroesophageal Reflux Disease.
J Clin Gastroenterol
; 57(4): 370-379, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35316226
2.
Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia.
BMC Nephrol
; 24(1): 18, 2023 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36658531
3.
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries.
Diabetes Obes Metab
; 24(7): 1277-1287, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35322567
4.
Healthcare resource utilization after initiation of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors or other glucose-lowering drugs in Japanese patients with type 2 diabetes.
Diabetes Obes Metab
; 23 Suppl 2: 28-39, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33835640
5.
Current trends in diabetes mellitus database research in Japan.
Diabetes Obes Metab
; 23 Suppl 2: 3-18, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33835639
6.
Lower heart failure and chronic kidney disease risks associated with sodium-glucose cotransporter-2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases.
Diabetes Obes Metab
; 23 Suppl 2: 19-27, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33835641
7.
Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study.
Diabetes Obes Metab
; 23(1): 75-85, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32893440
8.
A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia.
Clin Exp Nephrol
; 25(2): 140-149, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33098526
9.
Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT-5): 52-week results from a randomized, open-label, phase III clinical trial.
Diabetes Obes Metab
; 22(4): 540-548, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31742898
10.
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.
Diabetes Obes Metab
; 22(9): 1607-1618, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32363737
11.
Short-Term Efficacy (at 12 Weeks) and Long-Term Safety (up to 52 Weeks) of Omega-3 Free Fatty Acids (AZD0585) for the Treatment of Japanese Patients With Dyslipidemiaã- A Randomized, Double-Blind, Placebo-Controlled, Phase III Study.
Circ J
; 84(6): 994-1003, 2020 05 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-32281579
12.
Correction of serum potassium with sodium zirconium cyclosilicate in Japanese patients with hyperkalemia: a randomized, dose-response, phase 2/3 study.
Clin Exp Nephrol
; 24(12): 1144-1153, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32779057
13.
Pharmacokinetics and pharmacodynamics of dapagliflozin in combination with insulin in Japanese patients with type 1 diabetes.
Diabetes Obes Metab
; 21(4): 876-882, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30499157
14.
Oral esomeprazole in Japanese pediatric patients with gastric acid-related disease: Safety, efficacy, and pharmacokinetics.
Pediatr Int
; 61(1): 87-95, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30422368
15.
Efficacy and safety of dapagliflozin over 1 year as add-on to insulin therapy in Japanese patients with type 2 diabetes: the DAISY (Dapagliflozin Added to patients under InSulin therapY) trial.
Diabetes Obes Metab
; 19(4): 562-570, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-27987240
16.
Treatment patterns and trajectories in patients after acute heart failure hospitalization.
ESC Heart Fail
; 11(2): 692-701, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38098210
17.
ß1 integrin gene excision in the adult murine cardiac myocyte causes defective mechanical and signaling responses.
Am J Pathol
; 180(3): 952-962, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22248583
18.
Impact of chronic potassium binder treatment on the clinical outcomes in patients with hyperkalemia: Results of a nationwide hospital-based cohort study.
Front Physiol
; 14: 1156289, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37123269
19.
Evolution of sodium-glucose co-transporter 2 inhibitors from a glucose-lowering drug to a pivotal therapeutic agent for cardio-renal-metabolic syndrome.
Front Endocrinol (Lausanne)
; 14: 1111984, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36793276
20.
[Andexanet alfa (ONDEXXYA® for Intravenous Injection 200â mg), a reversal agent for direct factor Xa inhibitors: pharmacological characteristics and clinical evidence].
Nihon Yakurigaku Zasshi
; 158(1): 89-100, 2023.
Artículo
en Japonés
| MEDLINE | ID: mdl-36596498